NeuroOne Medical Technologies (NMTC) Financial Statements & Analysis

NeuroOne Medical Technologies (NMTC) Income Statement

NeuroOne Medical Technologies reported revenue of $12.10M in fiscal 2025 (fiscal year ended Sep 30, 2025), up 250.4% from $3.45M a year earlier. NeuroOne Medical Technologies posted a net loss of $3.61M, compared with a net loss of $12.32M a year earlier. Gross margin was 67.3% and operating margin -34.9%. In the most recent quarter, Q3 fiscal 2026 (ended Jun 30, 2026), revenue was $1.97M, up 16.3% from the same quarter a year earlier.

NeuroOne Medical Technologies Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

NeuroOne Medical Technologies Corporation income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Dec 2017
Revenue & Gross Profit
Revenue	12.10	3.45	1.95	0.17	0.24	1.93	0.00	0.00	0.00
Cost of Revenue	3.96	7.44	1.50	0.24	4.20	0.07	0.03	0.02	0.02
Gross Profit	8.14	1.08	0.46	-0.07	-0.03	1.86	-0.03	-0.02	-0.02
Operating Expenses
Research & Development	4.98	5.07	6.94	4.93	3.93	2.08	1.53	0.95	0.74
Selling, General & Administrative	7.38	7.90	6.93	6.98	6.26	4.75	4.28	3.54	2.34
Operating Expenses	12.37	12.97	12.41	9.96	10.19	6.76	5.81	3.19	3.07
Operating Income	-4.23	-11.89	-11.96	-10.03	-10.22	-4.90	-5.81	-3.21	-3.07
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.33	-0.10	0.00	0.00	0.00	7.52	0.28	0.00	1.40
Other Income/Expense	0.62	-0.43	0.10	0.03	0.27	-8.74	-0.97	-2.66	-1.99
Income
Income Before Tax	-3.61	-12.32	-11.86	-10.00	-9.95	-13.64	-6.78	-6.83	-5.06
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	-3.61	-12.32	-11.86	-10.00	-9.95	-13.64	-6.78	-6.83	-5.06
Net Income - Continuous Operations	-3.61	-12.32	-11.86	-10.00	-9.95	-13.64	-6.78	-6.83	-5.06
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	-3.01	-11.64	-11.66	-9.91	-10.14	-4.85	-5.79	-4.15	-3.05
EBIT	-3.27	-11.89	-11.86	-10.03	-10.22	-	-	-	-
Depreciation & Amortization	0.26	0.25	0.20	0.12	0.08	0.07	0.03	0.02	0.02
Earnings Per Share
Basic EPS	-1.00	-3.00	-4.00	-4.00	-6.00	-15.00	-10.00	-15.00	-14.00
Diluted EPS	-1.00	-3.00	-4.00	-4.00	-6.00	-15.00	-10.00	-15.00	-14.00
Basic Shares Outstanding	6.69	4.46	3.02	2.67	1.78	0.90	0.66	0.47	0.37
Diluted Shares Outstanding	6.69	4.46	3.02	2.67	1.78	0.90	0.66	0.47	0.37

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NeuroOne Medical Technologies Financial Statements

What was NeuroOne Medical Technologies's revenue in fiscal 2025?

NeuroOne Medical Technologies reported revenue of $12.10M in fiscal 2025 (fiscal year ended Sep 30, 2025). That was up 250.4% from $3.45M a year earlier.

Is NeuroOne Medical Technologies profitable?

No. NeuroOne Medical Technologies reported a net loss of $3.61M in fiscal 2025. In fiscal 2024 it lost $12.32M.

What is NeuroOne Medical Technologies's operating margin?

NeuroOne Medical Technologies's operating income was −$4.23M on revenue of $12.10M in fiscal 2025, an operating margin of -34.9%, compared with -344.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition